Pancreatic and periampullary tumors

Blair M. Rowitz, Douglas Brown, Barry C. Lembersky, Mark S. Roh

Research output: Chapter in Book/Report/Conference proceedingChapter


Approximately 27,000 new cases of pancreatic cancer were expected to be diagnosed in the United States in 1997. Although the pancreas is the tenth leading site in terms of new cancer diagnoses, the pancreas represents the fourth most common site of cancers causing death. Exocrine malignancies account for 95% of all pancreatic malignancies. Owing to the vague and nonspecific nature of symptoms, these tumors generally present late in their course. In fact, the average time from onset of symptoms to diagnosis of pancreatic carcinoma is 8 weeks. Thus, less than 10% of patients present with disease confined to the pancreas while nearly 50% have locally advanced disease and 40% have visceral metastases. The overall survival rate for pancreatic cancers has risen from 1% in the 1960s to 5% between 1986 and 1992. To date, site of origin and resectability remain the most important predictors of survival.

Original languageEnglish (US)
Title of host publicationIntegrated Cancer Management
Subtitle of host publicationSurgery, Medical Oncology, and Radiation Oncology
PublisherCRC Press
Number of pages20
ISBN (Electronic)9780824746780
ISBN (Print)9780824771959
StatePublished - Jan 1 1999
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pancreatic and periampullary tumors'. Together they form a unique fingerprint.

Cite this